Urinary Tract Infections (UTI) Testing
Understanding your test importance
Urinary Tract Infections (UTI) Testing
IDENTIFY 98-99%OF THE MOST COMMON URINARY TRACT PATHOGENS USING PCR
Rapidly detects bacterial, viral and fungal targets, eliminating the need for costly, inaccurate or time-consuming follow-up testing
Identifies presence of vancomycin and methicillin resistance genes, as well as multi-drug resistant and carbapenem resistant enterobacteriaceae.
Unaffected by current antibiotic use
Increased sensitivity and specificity (compared to traditional culture and sensitivity)
QUICKLY TARGET TREATMENT USING AN ACCURATE,DETAILED REPORT WITH ANTIBIOGRAM
Reduces potential unnecessary drug exposure, adverse events, costs of repeat testing and multiple treatment attempts
Aids in antibiotic stewardship by reducing over-utilization of broad spectrum anti-infectives
Estimated microbial load helps differentiate between pathogens and normal flora, where overgrowth of normal flora could cause infection in immunocompromised patients
Urinary Tract Infection Panel
Using real-time PCR, we can decrease unnecessary testing, health care cost, and improve satisfaction for patients due to faster and more accurate results. Within one day of receiving a sample, our lab can identify what organism(s) are responsible for a patient’s infection, and if they have antibiotic-resistant genes. PCR testing allows comprehensive, deeper in depth, reporting for more accurate results.
PCR TESTING
• Precisely analyzes genetic material of pathogens.
• Can be completed in 24-hours.
• Can identify a wider spectrum of microbes than an urine collection (viruses, bacteria, parasites, and fungi simultaneously).
• Provides a more definitive diagnosis.
• Analysis is not affected by current antibiotic use.
Pathogens Detected
• Staphylococcus aureus
• Staphylococcus Spp.
• Enterococcus faecalis
• Streptococcus agalactiae
• Escherichia coli
• Morganella morganii
• Klebsiella pneumonia
• Proteus mirabilis
• Pseudomonas aeruginosa
• Enterobacter cloacae
• Serratia marcescens
• Providence suartii
• Mycoplasma hominis
• Urea plasma urealyticum
UTI TESTING
- Acinetobacter baumanii
- Candida albicans,glabrata,parapsilosis, tropicalis
- Chlamydia trachomatis
- Citrobacter freundii
- Cytomegalovirus (CMV, Human Herpesvirus-5)
- Escherichia coli
- Enterobacter aerogenes, cloacae
- Enterococcusfaecalis, faecium
- Haemophilusinfluenzae
- Herpes simplex virus1 & 2 (HSV-1, HSV-2)
- Klebsiellapneumoniae, oxytoca
- Mycoplasmagenitalium, hominis
- Neisseriagonorrhoeae
- Proteusmirabilis, vulgaris
- Pseudomonasaeruginosa
- Serratiamarcescens
- Coagulase negative Staphylococci:
S. epidermidis, S.haemolytcus,
S. lugdunensis,
S.saprophytcus
- Staphylococcusaureus
- Streptococcusagalactiae (Group B strep (GBS))
- Streptococcuspyogenes (Group A strep (GAS))
- Treponemapallidum
- Trichomonasvaginalis
- Ureaplasmaurealyticum, parvum
UNIVERSAL MEDIA SAFELY INACTIVATES AND STABILIZES SAMPLE FOR TRANSPORT AND ANALYSIS.
ANTIBIOTIC RESISTANCE
• MACROLIDELINCOSAMIDE
STREPTOGRAMIN
• FLUOROQUINOLONE
• TETRACYCLINE
• CLASSA BETA LACTAMASE
• CLASSA BETA LACTAMASE
• CLASSBMETALLO BETA LACTAMASE
• AMPCBETA LACTAMASE
• CLASSD OXACILLINASE
• MINOREXTENDED SPECTRUM BETA LACTAMASES
• TRIMETHOPRIM/ SULFAMETHOXAZOLE
